Stock A061250 HWAIL PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Hwail Pharmaceutical Co.,Ltd.

Equities

A061250

KR7061250007

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 10/06/2024 am IST 		5-day change 1st Jan Change
1,512 KRW -0.66% Intraday chart for Hwail Pharmaceutical Co.,Ltd. +0.13% -31.43%
18/04 Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 19.0999977 billion in funding from Osung Advanced Materials Co., Ltd., Kumho HT, Inc., CrystalGenomics Invites Co., LTD. CI
27/03 PanGen Biotech Inc. announced that it has received KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd. CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hwail Pharmaceutical Co.,Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Hwail Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
Hwail Pharmaceutical Co.,Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Hwail Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A061250 Stock
  4. News Hwail Pharmaceutical Co.,Ltd.
  5. Other languages